Methodology for the control of intracranial pressure with hypertonic mannitol

Acta Neurochirurgica

Volumn 51, Issue 3-4, 1980, Pages 161-172

  James, H E ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTONIC SOLUTION; MANNITOL;

BRAIN EDEMA; CENTRAL NERVOUS SYSTEM; CONTINUOUS INFUSION; DRUG THERAPY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; THERAPY;

ADOLESCENT; ADULT; AGED; BRAIN EDEMA; CHILD; CHILD, PRESCHOOL; DIURETICS; HUMAN; HYPERTONIC SOLUTIONS; INFANT; INTRACRANIAL PRESSURE; MANNITOL; MIDDLE AGE; OSMOLAR CONCENTRATION;

EID: 0018849479     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/BF01406742     Document Type: Article

References (47)

1. Hyperosmolality with hyponatremia caused by inappropriate administration of mannitol
2. The effects of intravenous fluids on cerebrospinal fluid pressure
3. The alleviation of increased intracranial pressure by the chronic administration of osmotic agents
4. Controlled cerebral perfusion pressure and ventilation in human mechanical injury: prevention of progressive brain swelling
5. Effects of intravenously administered hypertonic urea solution
6. The influence of urea and mannitol on increased intraventricular pressure in cold-induced cerebral edema
7. Regional cerebral blood flow, intracranial pressure, and brain metabolism in comatose patients
8. The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise
9. Hypertonic urea in experimental cerebral edema
10. Treatment of experimental cerebral edema with intravenous hypertonic glucose, albumin, and dextran
11. Management of head injury by means of ventricular fluid pressure monitoring
12. Further studies on the effectiveness of agents used to lower intracranial pressure
13. Effects of isotonic intravenous solutions on normal and increased intracranial pressure
14. Intra-ocular and intracranial pressure: an experimental study
15. The effects of mannitol and urea on cerebral hemodynamics and cerebrospinal fluid pressure
16. Administration of urea for reduction of intracranial and intraocular pressure
17. The effect of urea on cerebrospinal fluid pressure in monkeys before and after bilateral nephrectomy
18. Analysis of therapeutic modalities for head injured children
19. Cytotoxic edema produced by 6-aminonicotinamide and its response to therapy
20. Methodology for intraventricular and subarachnoid continuous recording of intracranial pressure in clinical practice
21. Treatment of intracranial hypertension: Analysis of 105 consecutive, continuous recordings of intracranial pressure
22. Analysis of the response to therapeutic measures to reduce intracranial pressure in head injured patients
23. The effect of mannitol on cerebral blood flow: An experimental study
24. The effect of mannitol on intracranial pressure and cerebral blood flow
25. Reduction of raised intracranial pressure following infusion of mannitol
26. Possible mechanisms of action of hypertonic urea in reducing intracranial pressure
27. Intracranial volume-pressure relationships during experimental brain compression in primates. 3. Effects of mannitol and hyperventilation
28. Mannitol dose requirements in brain-injured patients
29. Effects of intravenous administration of hypertonic solutions of dextrose. With special reference to the cerebrospinal fluid pressure
30. Dehydration and rehydration of the brain with hypertonic urea and mannitol
31. Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients
32. Hypertonic urea: Its effect on the distribution of water and electrolytes in normal and edematous brain tissue
33. Stabilization and disturbance of csmoregulation in the cerebrospinal fluid
34. Effect of urea and acetazolamide on brain volume and cerebrospinal fluid pressure
35. Effect of hypertonic urea on cerebrospinal fluid pressure and brain volume
36. Computer-assisted analysis of intraventricular pressure after mannitol administration
37. Restricted fluid intake
38. The use of mannitol for the reduction of intracranial pressure in intracranial surgery
39. Mannitol-induced central nervous system toxicity in renal failure
40. Studies in experimental hypertonicity
41. Effects of repeated and massive mannitol infusion in the dog. Structural and functional changes in kidney and brain
42. Intraventricular pressure after administration of dehydrating agents to severely brain injured patients: Is there a rebound phenomenon?
43. Pressure changes in the cerebrospinal fluid following intravenous injection of solutions of various concentrations
44. Effects of infusion of hypertonic mannitol on electrolyte balance and on osmolarity of serum and cerebrospinal fluid
45. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure